AS Watson, the parent company of the UK health and beauty chain Superdrug, is advancing preparations for a stock market flotation valued at approximately £22 billion.
The company aims to complete the initial public offering before the end of 2026, marking a significant capital-raising event for the consumer healthcare giant.
Dr Malina Ngai, the chief executive of AS Watson, is currently in London to present the company’s strategy to potential investors.
Ngai, a former athlete who transitioned to corporate leadership, is spearheading the investor relations push as the company seeks to establish its public market valuation.
The presentation in the City underscores the urgency of the timeline, with the group targeting a year-end debut.
The proposed listing would make AS Watson one of the largest retail and healthcare IPOs in recent years.